{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:54:05Z","timestamp":1753890845919,"version":"3.41.2"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022293","name":"Direkt\u00f8r Throne Holsts Fond for Ern\u00e6ringsforskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022293","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Familial hypercholesterolemia (FH) is a common, inherited disease characterized by high levels of low-density lipoprotein Cholesterol (LDL-C) from birth. Any diseases associated with increased LDL-C levels including atherosclerotic cardiovascular diseases (ASCVDs) would be expected to be overrepresented among FH patients. There are several clinical scoring systems aiming to diagnose FH, however; most individuals who meet the clinical criteria for a FH diagnosis do not have a mutation causing FH. In this review, we aim to summarize the literature on the risk for the various forms of ASCVD in subjects with a proven FH-mutation (FH+). We searched for studies on FH+ and cardiovascular diseases and also included our and other groups published papers on FH + on a wide range of cardiovascular and other diseases of the heart and vessels. FH + patients are at a markedly increased risk of a broad range of ASCVD. Acute myocardial infarction (AMI) is the most common in absolute numbers, but also aortic valve stenosis is by far associated with the highest excess risk. Per thousand patients, we observed 3.6 incident AMI per year compared to 1.9 incident aortic valve stenosis, however, standardized incidence ratio (SIR) for incident AMI was 2.3 compared to 7.9 for incident aortic valve stenosis. Further, occurrence of ischemic stroke seems not to be associated with increased risk in FH+. Clinicians should be aware of the excess risk of almost all kind of ASCVD in FH+, and the neutral risk of stroke need to be studied further in FH + patients.<\/jats:p>","DOI":"10.3389\/fgene.2022.1072108","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T06:37:49Z","timestamp":1670308669000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["The risk of various types of cardiovascular diseases in mutation positive familial hypercholesterolemia; a review"],"prefix":"10.3389","volume":"13","author":[{"given":"Anders","family":"Hovland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liv J.","family":"Mundal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marit B.","family":"Veier\u00f8d","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten B.","family":"Holven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin Pr\u00f8ven","family":"Bogsrud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grethe S.","family":"Tell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trond P.","family":"Leren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kjetil","family":"Retterst\u00f8l","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","article-title":"Lipoprotein(a) levels in familial hypercholesterolemia: An important predictor of cardiovascular disease independent of the type of LDL receptor mutation","volume":"63","author":"Allara","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.jacl.2016.04.006","article-title":"Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry","volume":"10","author":"Alonso","year":"2016","journal-title":"J. Clin. Lipidol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/j.jacc.2017.08.009","article-title":"Genetically confirmed familial hypercholesterolemia in patients with acute coronary syndrome","volume":"70","author":"Amor-Salamanca","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"560958","DOI":"10.3389\/fphar.2020.560958","article-title":"Risk of recurrent coronary events in patients with familial hypercholesterolemia; A 10-years prospective study","volume":"11","author":"Arnesen","year":"2020","journal-title":"Front. Pharmacol"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2021.01.010","article-title":"Characteristics and trends of PCSK9 inhibitor prescription fills in the United States","author":"Attipoe-Dorcoo","year":"2021","journal-title":"J. Clin. Lipidol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1161\/CIRCULATIONAHA.118.033470","article-title":"Relationship of familial hypercholesterolemia and high low-density lipoprotein cholesterol to ischemic stroke: Copenhagen general population study","volume":"138","author":"Beheshti","year":"2018","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2013.12.020","article-title":"Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: A study of a cohort of 14, 000 mutation carriers","volume":"233","author":"Besseling","year":"2014","journal-title":"Atherosclerosis"},{"key":"B8","article-title":"Lipids and vascular disease: Current issues","author":"Betteridge","year":"2000","journal-title":"Taylor Francis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jacl.2019.01.010","article-title":"LDL-cholesterol goal achievement, cardiovascular disease, and attributed risk of Lp(a) in a large cohort of predominantly genetically verified familial hypercholesterolemia","volume":"13","author":"Bogsrud","year":"2019","journal-title":"J. Clin. Lipidol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jacl.2020.04.002","article-title":"Prevalence of genetically verified familial hypercholesterolemia among young (<45 years) Norwegian patients hospitalized with acute myocardial infarction","volume":"14","author":"Bogsrud","year":"2020","journal-title":"J. Clin. Lipidol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1034\/j.1399-0004.2002.610603.x","article-title":"LDL receptor mutation genotype and vascular disease phenotype in heterozygous familial hypercholesterolaemia","volume":"61","author":"Brorholt-Petersen","year":"2002","journal-title":"Clin. Genet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1161\/01.ATV.0000177811.14176.2b","article-title":"Tendon xanthomas in familial hypercholesterolemia are associated with cardiovascular risk independently of the low-density lipoprotein receptor gene mutation","volume":"25","author":"Civeira","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.jacc.2020.07.059","article-title":"Time course of LDL cholesterol exposure and cardiovascular disease event risk","volume":"76","author":"Domanski","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2021.05.006","article-title":"ANKS1A genotype predicts cardiovascular events in patients with familial hypercholesterolemia,","author":"Fantino","year":"2021","journal-title":"J. Clin. Lipidol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1016\/j.jcmg.2021.06.011","article-title":"The added value of coronary calcium score in predicting cardiovascular events in familial hypercholesterolemia","volume":"14","author":"Gallo","year":"2021","journal-title":"JACC. Cardiovasc. Imaging"},{"key":"B16","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group","volume":"303","author":"Group","year":"1991","journal-title":"BMJ"},{"key":"B17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/eurheartj\/ehx373","article-title":"Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke","volume":"39","author":"Hopewell","year":"2018","journal-title":"Eur. Heart J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2017.09.027","article-title":"Increased risk of heart failure and atrial fibrillation in heterozygous familial hypercholesterolemia","volume":"266","author":"Hovland","year":"2017","journal-title":"Atherosclerosis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1161\/STROKEAHA.118.023456","article-title":"Risk of ischemic stroke and total cerebrovascular disease in familial hypercholesterolemia","volume":"50","author":"Hovland","year":"2019","journal-title":"Stroke"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: A systematic review and meta-analysis","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1161\/CIRCULATIONAHA.120.046961","article-title":"What is familial hypercholesterolemia, and Why Does it matter","volume":"141","author":"Khera","year":"2020","journal-title":"Circulation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e005435","DOI":"10.1161\/JAHA.116.005435","article-title":"Long-term cardiovascular risk in heterozygous familial hypercholesterolemia relatives identified by cascade screening","volume":"6","author":"Kj\u00e6rgaard","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"B23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.atherosclerosis.2004.10.042","article-title":"Effect of low-density lipoprotein receptor mutation on lipoproteins and cardiovascular disease risk: A parent-offspring study","volume":"180","author":"Koeijvoets","year":"2005","journal-title":"Atherosclerosis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1093\/eurheartj\/ehv602","article-title":"Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death","volume":"37","author":"Krogh","year":"2016","journal-title":"Eur. Heart J."},{"key":"B25","article-title":"Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk","author":"Lee","year":"2019","journal-title":"J. Prev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2019","journal-title":"Eur. Heart J."},{"key":"B27","unstructured":"MedPedProgramU. S.\n          2005"},{"key":"B28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/2047487316676135","article-title":"Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013","volume":"24","author":"Mundal","year":"2017","journal-title":"Eur. J. Prev. Cardiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1001\/jamacardio.2019.3903","article-title":"Association of low-density lipoprotein cholesterol with risk of aortic valve stenosis in familial hypercholesterolemia","volume":"4","author":"Mundal","year":"2019","journal-title":"JAMA Cardiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.ejvs.2020.12.019","article-title":"Excess aortic pathology risk in patients with genetically verified familial hypercholesterolaemia: A prospective Norwegian registry study","volume":"61","author":"Mundal","year":"2021","journal-title":"Eur. J. Vasc. Endovascular Surg."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1093\/eurjpc\/zwaa024","article-title":"Increased risk of peripheral artery disease in persons with familial hypercholesterolaemia: A prospective registry study","volume":"28","author":"Mundal","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e227715","DOI":"10.1001\/jamanetworkopen.2022.7715","article-title":"Association of familial hypercholesterolemia and statin use with risk of dementia in Norway","volume":"5","author":"Mundal","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1136\/heartjnl-2017-312706","article-title":"Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia","volume":"104","author":"Mundal","year":"2018","journal-title":"Heart"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e001236","DOI":"10.1161\/JAHA.114.001236","article-title":"Mortality among patients with familial hypercholesterolemia: A registry-based study in Norway, 1992-2010","volume":"3","author":"Mundal","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1177\/2047487316666371","article-title":"Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study","volume":"23","author":"Mundal","year":"2016","journal-title":"Eur. J. Prev. Cardiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jacl.2017.03.019","article-title":"Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia","volume":"11","author":"Paquette","year":"2017","journal-title":"J. Clin. Lipidol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.jacl.2019.06.011","article-title":"Individuals with familial hypercholesterolemia and cardiovascular events have higher circulating Lp(a) levels","volume":"13","author":"Pavanello","year":"2019","journal-title":"J. Clin. Lipidol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1093\/eurheartj\/ehx653","article-title":"Calcific aortic valve stenosis: Hard disease in the heart: A biomolecular approach towards diagnosis and treatment","volume":"39","author":"Peeters","year":"2018","journal-title":"Eur. Heart J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.atherosclerosis.2015.07.022","article-title":"Peripheral arterial disease in heterozygous familial hypercholesterolemia","volume":"242","author":"Pereira","year":"2015","journal-title":"Atherosclerosis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1161\/ATVBAHA.116.307514","article-title":"Coronary heart disease, peripheral arterial disease, and stroke in familial hypercholesterolaemia: Insights from the SAFEHEART registry (Spanish familial hypercholesterolaemia cohort study)","volume":"36","author":"P\u00e9rez de Isla","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1093\/eurheartj\/ehaa1066","article-title":"Lipoprotein(a), LDL-cholesterol, and hypertension: Predictors of the need for aortic valve replacement in familial hypercholesterolaemia","volume":"42","author":"Perez de Isla","year":"","journal-title":"Eur. Heart J."},{"key":"B42","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/nejmoa2004215","article-title":"Evinacumab for homozygous familial hypercholesterolemia","volume":"383","author":"Raal","year":"2020","journal-title":"N. Engl. J. Med. Overseas. Ed."},{"key":"B43","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.clinbiochem.2011.11.001","article-title":"The logarithm of the triglyceride\/HDL-cholesterol ratio is related to the history of cardiovascular disease in patients with familial hypercholesterolemia","volume":"45","author":"So\u0161ka","year":"2012","journal-title":"Clin. Biochem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.atherosclerosis.2020.12.019","article-title":"2.5-fold increased risk of recurrent acute myocardial infarction with familial hypercholesterolemia","volume":"319","author":"Svendsen","year":"2021","journal-title":"Atherosclerosis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.atherosclerosis.2022.08.015","article-title":"Risk of stroke in genetically verified familial hypercholesterolemia: A prospective matched cohort study","volume":"358","author":"Svendsen","year":"2022","journal-title":"Atherosclerosis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jacc.2019.05.043","article-title":"Risk of premature atherosclerotic disease in patients with monogenic versus polygenic familial hypercholesterolemia","volume":"74","author":"Trinder","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1161\/01.cir.0000041253.61683.08","article-title":"Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population","volume":"106","author":"Umans-Eckenhausen","year":"2002","journal-title":"Circulation"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: A report from the American heart association","volume":"141","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.atherosclerosis.2016.01.023","article-title":"The effect of statins on valve function and calcification in aortic stenosis: A meta-analysis","volume":"246","author":"Zhao","year":"2016","journal-title":"Atherosclerosis"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.1072108\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T06:37:57Z","timestamp":1670308677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.1072108\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,6]]},"references-count":49,"alternative-id":["10.3389\/fgene.2022.1072108"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.1072108","relation":{},"ISSN":["1664-8021"],"issn-type":[{"type":"electronic","value":"1664-8021"}],"subject":[],"published":{"date-parts":[[2022,12,6]]},"article-number":"1072108"}}